Wang Cheng, Secretary of the Party Committee and Chairman of Sichuan Energy Investment, and his team visited Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as Chipscreen Biosciences) on March 18 for field inspection and survey. A panel meeting was held, focusing on Chipscreen Biosciences' development history, R&D progress, industry challenges, and future high-quality development. Yang Yang and He Lianjun, Deputy General Managers of Sichuan Energy Investment, and Lu Xianping, Chairman of Chipscreen Biosciences, participated in the inspection and survey. 

 
At the headquarters of Chipscreen Biosciences, Wang Cheng and his team visited the Company's early R&D center and technology transfer center to learn more about the Company's R&D layout, technological innovation platform, and product pipeline progress. Subsequently, the two parties held a symposium to discuss the industrial development trend, scientific research focus, and future development.

Dr. Lu Xianping expressed his gratitude for the care and support of Sichuan Energy Investment and provided a detailed description of the Company's development history, basic information, and scientific research achievements. He pointed out that the inclusion of innovative drugs in the government work report for the first time in the National People's Congress and the Chinese People's Political Consultative Conference boosts confidence in the pharmaceutical industry. Chipscreen Biosciences will always keep in mind the instructions of General Secretary Xi Jinping on "self-reliance and self-improvement in science and technology", actively carry out collaborative research guided by urgent clinical needs, and develop more innovative drugs with revolutionary therapeutic effects.
 
Wang Cheng expressed admiration for Dr. Lu Xianping and his team's commitment to developing innovative drugs for the past 23 years and highly appreciated the achievements of Chipscreen Biosciences in self-reliance of innovative drugs. He emphasized that Sichuan Energy Investment should develop new quality productive forces according to local conditions while solidifying traditional advantages in the new energy industry. As the first majority shareholder of Chipscreen Biosciences, Sichuan Energy Investment will actively give full play to the advantages of industrial groups, provide strong support in areas such as preference policies, resource access, and fund guarantee to help Chipscreen Biosciences achieve scientific and technological innovations and attain high-quality development.
 
Leaders from the Office, Investment Development Department, and Capital Operation Department of Sichuan Energy Investment as well as Tsinghua Holdings, Jinding Group, and Material Industry Group to Sichuan Energy Investment, Li Jianxun, Deputy General Manager of Chipscreen Biosciences, and Hai Ou, Deputy General Manager and Chairman Secretary of Chipscreen Biosciences, participated in the inspection and survey.